ACTUATE THERAPEUTICS, INC. — Form 10-Q
Filed August 14, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 5/100
What the filing says
Actuate Therapeutics filed its Form 10-Q for the quarter ended June 30, 2026 on August 14, 2026. The filing header contains only administrative metadata (SEC accession number, filing date, document list, and company contact information); no material financial results, cash position, clinical trial data, partnership announcements, capital raises, or operational changes are disclosed in this excerpt. Full analysis requires review of the actual 10-Q document body (file 1, 627997 bytes).
Why this rating
Header metadata only; no substantive business information disclosed. Routine quarterly filing administrative submission.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.